Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Original principal investigator left the university before enrollment started
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
For the end stage renal disease (ESRD) patients undergoing hemodialysis treatment, specifically, reflex mediated calf muscle pump stimulation has the potential to significantly reduce the number and magnitude of hypotensive episodes thus enhancing the effectiveness of the dialysis process. Fewer hemodialysis complications during the patient's hemodialysis treatment, would allow treatment sessions to continue to the prescribed volume removal, with much reduced patient recovery time, and the costs associated with this recovery.
Recruit individuals who consistently miss their dialysis goal. Maintain the goal over a six week period of time. Utilize exogenous calf muscle pump stimulation during each dialysis session to enhance fluid return from the lower limbs with the objective of assisting the patient in reaching ultrafiltration goal.
Track number of hypotensive events during dialysis, as well as goal success.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Calf Muscle Pump Stimulation | Experimental | Subjects serve as self-control. Six weeks of dialysis data without intervention will be compared to six weeks post intervention |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Calf Muscle Pump Stimulation | Device | Stimulation of the postural reflex arc to activate the soleus muscle during dialysis |
|
| Measure | Description | Time Frame |
|---|---|---|
| Achievement of ultrafiltration goal | Fraction of dialysis treatments where microfiltration target was achieved during 6 week period | 6 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Hypotensive events | Number of hypotensive events experienced during dialysis over six week time period | 6 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kenneth J. McLeod, Ph.D. | Clinical Science and Engineering Research Center | Principal Investigator |
Not provided
Team is willing to share anonymous data with interested investigators
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007022 | Hypotension |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided